Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Olaparib Impurity 33

Olaparib Impurity 33 is listed in the pharmaceutical impurity collection under CAS 550363-85-4. Its represented structure has formula C8H5FO3 and a calculated molecular weight of 168.12 g/mol.

2D chemical structure

O F O H O

Chemical identity

Catalog name
Olaparib Impurity 33
Common name
Olaparib Impurity 33
Chemical name
2-fluoro-5-formylbenzoic acid
CAS
550363-85-4
SMILES
O=Cc1ccc(F)c(C(=O)O)c1
InChI
InChI=1S/C8H5FO3/c9-7-2-1-5(4-10)3-6(7)8(11)12/h1-4H,(H,11,12)
InChIKey
XZUFXXPSLGVLFC-UHFFFAOYSA-N
Associated API
Olaparib

Record ID: Ab911355452e7

Computed properties

C8H5FO3 Molecular formula
168.123 g/molMolecular weight
168.0223 DaMonoisotopic exact mass
54.37 ŲTopological polar surface area
1.3364 Calculated LogP (Wildman–Crippen)
38.7468 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H O 0 2 4 6 8 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight168.1239.70
Calculated LogP (Wildman–Crippen)1.336430.70
Topological polar surface area54.3735.22
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)224.16

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC8H5FO3dimensionless
Molecular weight168.123g/mol
Monoisotopic exact mass168.0223Da
Topological polar surface area54.37Ų
Calculated LogP (Wildman–Crippen)1.3364dimensionless
Molar refractivity (Wildman–Crippen)38.7468cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)2count
Heavy atoms12count
Heteroatoms4count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area67.4441Ų
Valence electrons62count
Radical electrons0count
Bertz complexity333.0749index
Balaban J3.2542index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Olaparib Impurity 33

Qualification and safety assessment of Olaparib Impurity 33

Explore toxicological qualification of Olaparib Impurity 33 and ICH M7 mutagenic impurity assessment of Olaparib Impurity 33 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Olaparib Impurity 33 and acceptable intake and limit justification for Olaparib Impurity 33. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Olaparib Impurity 33

Explore Altox services and software through the Altox Pharma-Hub.